Liu JF, Xiong N, Wenham RM, Wahner-Hendrickson A, et al. A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib. Gynecol Oncol 2024;187:105-112.
PMID: 38759516